<DOC>
	<DOCNO>NCT00000673</DOCNO>
	<brief_summary>AMENDED : 04-12-91 Population patient change FROM intolerant systemic therapy NON-sight-threatening CMV retinitis TO AIDS patient intolerant systemic therapy CMV retinitis . AMENDED : 8/8/90 . Changes make neutrophil count &lt; 500 &lt; 750 cells/mm3 . Nonrandomized eye use primary efficacy evaluation . ORIGINAL DESIGN : To determine effectiveness safety ganciclovir ( DHPG ) therapy AIDS patient suffer active cytomegalovirus ( CMV ) infection retina eye ( retinitis ) drug administer directly fluid-filled vitreous cavity eye injection . CMV retinitis frequently see opportunistic infection eye AIDS patient , leave untreated lead severe visual loss blindness . While systemic administration DHPG show effective treatment CMV retinitis , chronic administration require may complicate decrease blood cell count ( granulocytopenia ) may require discontinuation treatment . While withhold treatment may allow recovery granulocytopenia , interruption therapy may result reactivation retinitis . Injection DHPG vitreous cavity eye may benefit severely neutropenic patient CMV retinitis .</brief_summary>
	<brief_title>A Phase I/II Open-Labelled Trial Intravitreal Ganciclovir Salvage Therapy AIDS Patients With Active CMV Retinitis Who Are Intolerant Systemic Therapy</brief_title>
	<detailed_description>CMV retinitis frequently see opportunistic infection eye AIDS patient , leave untreated lead severe visual loss blindness . While systemic administration DHPG show effective treatment CMV retinitis , chronic administration require may complicate decrease blood cell count ( granulocytopenia ) may require discontinuation treatment . While withhold treatment may allow recovery granulocytopenia , interruption therapy may result reactivation retinitis . Injection DHPG vitreous cavity eye may benefit severely neutropenic patient CMV retinitis . Patients must active CMV retinitis one eye , despite prior systemic therapy . Following medical evaluation , decision make whether treat eye ( ) immediately watch eye ( ) carefully advancement retinitis . Eyes sight-threatening lesion eye without functional vision treat immediately eye without sight-threatening lesion randomly choose either immediate deferred therapy . DHPG give injection fine needle twice week first 3 week week remain 24 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Zidovudine ( AZT ) . AMENDED : 8/8/90 Other available antiretroviral therapy . Pneumocystis carinii pneumonia ( PCP ) prophylaxis , either systemic local ( aerosolize ) . Chemotherapy Kaposi 's sarcoma . Systemic therapy intercurrent opportunistic infection . Acyclovir treatment Herpes simplex virus ( HSV ) Varicella zoster virus ( VZV ) infection . Systemic therapy deem necessary appropriate medical management . Patients must AIDS cytomegalovirus ( CMV ) retinitis least one eye , diagnosed ophthalmologist verify fundoscopy fundus photography . Exclusion Criteria Coexisting Condition : Patients follow exclude : Contraindication intravitreal injection , include obvious external infection vitreous hemorrhage . Medical opacity cornea , lens , and/or vitreous precludes fundus photography . Concurrent Medication : Excluded : Prophylactic acyclovir time study entry . Other anticytomegalovirus ( CMV ) therapy , particularly systemic ganciclovir , foscarnet , CMV hyperimmune globulin . Topical ophthalmic medication avoid . Cytomegalovirus ( CMV ) therapies chronic acyclovir , include necessary therapy intercurrent opportunistic infection . Patients follow exclude : Contraindication intravitreal injection , include obvious external infection vitreous hemorrhage . Medical opacity cornea , lens , and/or vitreous precludes fundus photography .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Retinitis</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Cytomegalovirus Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>